Future studies should focus on developing more efficient TP73-AS1-targeted inhibition strategies and elucidating its molecular mechanisms in tumor drug resistance, thereby providing new theoretical foundations and therapeutic approaches for cancer treatment. Here, TP73 is linked to neoplasm.